19/11/2021 ANVISA simplifies authorization for Research Institutions that intend to acquire and use cannabis-derived products to develop teaching and research activities
23/07/2020 ANVISA defines criteria and procedures to make compliance with technical requirements for labeling and package inserts more flexible
7/07/2020 To face the COVID-19 pandemic, ANVISA amends norm so that advanced therapy products not eligible for registration can already be used in Brazil
2/07/2020 ANVISA eases compliance of technical requirements of Good Manufacturing Practices and Import of Medication and Pharmaceutical Supplies
